Icahn School Of Medicine At Mount Sinai
Clinical trials sponsored by Icahn School Of Medicine At Mount Sinai, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Could a simple shot make hysteroscopy Pain-Free? Results expected Sep 2026 (estimated)
- Camera vs. needle: study aims to speed up cancer diagnosis in lung fluid patients Results expected Sep 2026 (estimated)
- VR meditation may help voice disorder patients find their voice Results expected Sep 2026 (estimated)
- Mammograms may reveal hidden heart risks – new study tests if telling women saves lives Results expected Sep 2026 (estimated)
- New MRI scan could replace painful liver biopsies for MASH patients Results expected Oct 2026 (estimated)
-
Can a skin ointment calm two stubborn redness conditions?
Disease control Stopped earlyThis phase 2 trial tests whether a once-daily topical ointment called PF-07038124 can ease moderate-to-severe seborrheic dermatitis and papulopustular rosacea. Adults with either condition will apply the ointment or a placebo for 8 weeks, with follow-up visits to check skin impro…
Phase 2 • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
New spinal implant studied for osteoporosis fractures
Disease control Stopped earlyThis study tested a new device called the Vertebral Implant PEEK (VIP) for people with spine fractures due to osteoporosis. The goal was to see if the implant is safe and helps repair the broken bone. The study included 23 adults aged 50 and older with recent fractures that did n…
Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
Promising drug for rare skin ulcers shows early potential
Disease control Stopped earlyThis study tested a drug called spesolimab in 5 adults with moderate to severe pyoderma gangrenosum, a rare autoimmune disease that causes painful skin ulcers. The goal was to see if the drug could help heal the ulcers and to understand how the body's immune system responds. The …
Phase 2 • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Cream combo tested for scalp bumps in men of african descent
Disease control Stopped earlyThis study tested Duobrii, a prescription cream that combines a strong steroid with a retinoid, for treating early-mild acne keloidalis nuchae (AKN) — a chronic scalp condition causing bumps and scarring, mainly in men of African descent. The trial planned to enroll 15 adults wit…
Phase 3 • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
New brain wave test could spot concussions faster
Diagnosis Stopped earlyThis study tested a new, non-invasive EEG device that uses flashing lights to detect concussions. Researchers compared the device's results to standard doctor assessments in 150 people with head injuries and healthy controls. The goal was to see if the device could accurately fla…
Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Diagnosis
Last updated Jun 27, 2026 12:34 UTC
-
NYC school program aims to boost Kids' heart health
Prevention Stopped earlyThis study tested a health program in New York City elementary schools to help children develop better heart-healthy habits, like eating well, being active, and getting enough sleep. Over 1,200 children took part, and researchers measured their overall heart health score. The pro…
Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Prevention
Last updated Jun 27, 2026 07:56 UTC
-
Could a simple pill replace IVs for migraines in the ER?
Symptom relief Stopped earlyThis study looked at two FDA-approved migraine medications (a dissolving tablet and a nasal spray) given to adults in the emergency department. The goal was to see if these easy-to-use options could relieve pain quickly and shorten ER visits. The study was stopped early with only…
Phase 4 • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Symptom relief
Last updated Jun 27, 2026 12:25 UTC
-
App-Based knee pain therapy tested against In-Person care
Symptom relief Stopped earlyThis study tested whether a digital home exercise program (SimpleTherapy) could work as well as standard in-person physical therapy for people with chronic knee osteoarthritis pain. The plan was to have 32 adults with knee pain do exercises at home three times a week for six week…
Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Symptom relief
Last updated Jun 27, 2026 09:02 UTC
-
Can a video game rewire the brain to ease PTSD?
Symptom relief Stopped earlyThis pilot study tested a digital training task called GAMBIT in 50 adults with PTSD. The goal was to see if playing this brain-training game could improve brain circuit flexibility and reduce PTSD symptoms. The study was terminated early, so the findings are limited.
Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Symptom relief
Last updated Jun 27, 2026 07:53 UTC
-
Mindfulness therapy for picky eaters? study halted early
Knowledge-focused Stopped earlyThis study tested a new therapy that combines mindfulness and exposure to body sensations for teens with avoidant/restrictive food intake disorder (ARFID), where eating is very limited. The goal was to see if the therapy was acceptable and could increase the number of foods eaten…
Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
Can smart alerts stop Post-Surgery confusion in Memory-Impaired patients?
Knowledge-focused Stopped earlyThis study tested whether computer alerts in medical records could help prevent postoperative delirium (sudden confusion after surgery) in patients with cognitive impairment. Researchers used machine learning to identify high-risk patients and prompted anesthesiologists with 12 b…
Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC
-
Heart study explores Yoga's effect on genes
Knowledge-focused Stopped earlyThis study tested whether a 16-week program of yoga and lifestyle changes could affect gene activity (micro RNA) and heart disease risk factors in 16 adults with coronary artery disease. Participants had either undergone a heart procedure or had non-obstructive heart disease with…
Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC